5-HT1A Serotonergic, α-Adrenergic and Opioidergic Receptors Mediate the Analgesic Efficacy of Vortioxetine in Mice

2014, Vortioxetine: A review of its use in major depressive disorder, CNS Drugs, 28, 855, 10.1007/s40263-014-0195-x

Sanchez, 2015, Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data, Pharm. Ther., 145, 43, 10.1016/j.pharmthera.2014.07.001

Pehrson, 2012, Pharmacological effects of Lu AA21004: A novel multimodal compound for the treatment of major depressive disorder, J. Pharm. Exp. Ther., 340, 666, 10.1124/jpet.111.189068

Pehrson, 2013, Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters-a rat microdialysis and electrophysiology study, Eur. Neuropsychopharmacol., 23, 133, 10.1016/j.euroneuro.2012.04.006

Moore, 2008, Lu AA21004: A novel potential treatment for mood disorders, Eur. Neuropsychopharmacol., 18, 321, 10.1016/S0924-977X(08)70440-1

Montezinho, 2013, Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats, Pharmacol. Biochem. Behav., 105, 41, 10.1016/j.pbb.2013.01.019

Pehrson, 2013, Vortioxetine, a novel multimodal antidepressant, modulates GABA and glutamate neurotransmission via serotonergic mechanisms, Eur. Neuropsychopharmacol., 23, 196, 10.1016/S0924-977X(13)70301-8

Ozbeyli, 2019, Protective effects of vortioxetine in predator scent stress model of post-traumatic stress disorder in rats: Role on neuroplasticity and apoptosis, J. Physiol. Pharm., 70, 557

Shah, 2018, An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder, Ann. Gen. Psychiatry, 17, 1, 10.1186/s12991-018-0190-6

2019, The effect of vortioxetine on penicillin-induced epileptiform activity in rats, Arq. Neuropsiquiatr., 77, 412, 10.1590/0004-282x20190064

Berrocoso, 2009, Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice, Int. J. Neuropsychopharmacol., 12, 61, 10.1017/S1461145708008766

Bomholt, 2005, Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain, Neuropharmacology, 48, 252, 10.1016/j.neuropharm.2004.09.012

Cartmell, 1991, A revised rotarod procedure for measuring the effect of antinociceptive drugs on motor function in the rat, J. Pharmacol. Methods, 6, 149, 10.1016/0160-5402(91)90063-B

Kasap, 2016, Opioid system mediated anti-nociceptive effect of agomelatine in mice, Life Sci., 15, 55, 10.1016/j.lfs.2016.08.031

Guilloux, 2013, Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice, Neuropharmacology, 73, 147, 10.1016/j.neuropharm.2013.05.014

Zuena, 2018, Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain, Mol. Pain, 14, 1, 10.1177/1744806918808987

Gozariu, 2001, Animal models of nociception, Pharmacol. Rev., 53, 597

Shajib, 2018, Polymethoxyflavones from Nicotiana plumbaginifolia (Solanaceae) exert antinociceptive and neuropharmacological effects in mice, Front. Pharmacol., 9, 1, 10.3389/fphar.2018.00085

Micov, 2020, Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy, Prog. Neuropsychopharmacol. Biol. Psychiatry, 103, 109975, 10.1016/j.pnpbp.2020.109975

Bang-Andersen, B., Faldt, A., Moerk, A., Lopez De Diego, H., Holm, R., Stensboel, T.B., Ringgaard, L.M., Mealy, M.J., Rock, M.H., and Brodersen, J. (2007). 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] Piperazine as a Compound with Combined Serotonin Reuptake, 5-HT3 and 5-HT1A Activity for the Treatment of Cognitive Impairment. (WO 2007/144005 A1).

Moore, N., and Stensboel, T.B. (2008). 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] Piperazine as a Compound with Combined Serotonin Reuptake, 5-HT3 and 5-HT1A Activity for the Treatment of Pain or Residual Symptoms in Depression Relating to Sleep and Cognition. (WO 2008/113359 A2).

Holden, 2005, The endogenous opioid system and clinical pain management, AACN Clin. Issues, 16, 291, 10.1097/00044067-200507000-00003

Millan, 2002, Descending control of pain, Prog. Neurobiol., 66, 355, 10.1016/S0301-0082(02)00009-6

Yaksh, 1985, Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing, Pharmacol. Biochem. Behav., 22, 845, 10.1016/0091-3057(85)90537-4

Koe, 1996, p-Chlorophenylalanine: A specific depletor of brain serotonin, J. Pharmacol. Exp. Ther., 154, 499

Jacobs, 2010, Serotonin in pain and pain control, Handbook of Behavioral Neurobiology of Serotonin, Volume 21, 462

Jaime, 2018, Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 receptors and their role in the modulation of pain response in the central nervous system, Curr. Neuropharmacol., 16, 210

Marlier, 1991, Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord, Brain Res., 550, 15, 10.1016/0006-8993(91)90400-P

Daval, 1987, Autoradiographic evidence of serotonin 1 binding sites on primary afferent fibers in the dorsal horn of the rat spinal cord, Neurosci. Lett., 83, 71, 10.1016/0304-3940(87)90218-7

Jeong, 2012, Role of 5-HT1 receptor subtypes in the modulation of pain and synaptic transmission in rat spinal superficial dorsal horn, Br. J. Pharm., 165, 1956, 10.1111/j.1476-5381.2011.01685.x

Nadeson, 2002, Antinociceptive role of 5-HT1A receptors in rat spinal cord, Br. J. Anaesth., 88, 679, 10.1093/bja/88.5.679

Gjerstad, 1996, The effect of 5-HTIA receptor stimulation on nociceptive dorsal horn neurones in rats, Eur. J. Pharm., 318, 315, 10.1016/S0014-2999(96)00819-9

Eide, 1990, The role of spinal cord 5-HT1A and 5-HT1B receptors in the modulation of a spinal nociceptive reflex, Brain Res., 536, 195, 10.1016/0006-8993(90)90025-7

Bardin, 2018, NLX-112, a highly selective 5-HT 1A receptor agonist, mediates analgesia and antidepressant-like activity in rats via spinal cord and prefrontal cortex 5-HT 1A receptors, respectively, Brain Res., 1688, 1, 10.1016/j.brainres.2018.03.016

Rojek, 2017, Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT1A receptor selective agonist, NLX-112 in mouse models of pain, Neuropharmacology, 125, 181, 10.1016/j.neuropharm.2017.07.022

Valhondo, 2013, New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo, J. Med. Chem., 56, 7851, 10.1021/jm400766k

Bardin, 2003, Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain, Pharmacology, 67, 182, 10.1159/000068404

Giordano, 1992, Putative mechanisms of buspirone-induced antinociception in the rat, Pain, 50, 365, 10.1016/0304-3959(92)90042-A

Lewander, 1978, Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-methyl-p-tyrosine; time- and dose–response relationships, Naunyn Schmiedebergs Arch. Pharm., 304, 111, 10.1007/BF00495547

Mayorga, 2001, Antidepressant-like behavioral effects in 5-hydroxytryptamine (1A) and 5-hydroxytryptamine (1B) receptor mutant mice, J. Pharm. Exp. Ther., 298, 1101

Baba, 2000, Norepinephrine facilitates inhibitory transmission in substantia gehtinosa of adult rat spinal cord (Part 1): Effects on axon terminals of GABAergic and glycinergic neurons, Anesthesiology, 92, 473, 10.1097/00000542-200002000-00030

Fukui, 2001, Involvement of β2-adrenergic and µ-opioid receptors in antinociception produced by intracerebroventricular administration of α, β-methylene-ATP, Jpn. J. Pharm., 86, 423, 10.1254/jjp.86.423

Pertovaara, 2006, Noradrenergic pain modulation, Prog. Neurobiol., 80, 53, 10.1016/j.pneurobio.2006.08.001

Sonohata, 2004, Actions of noradrenaline on substantia gelatinosa neurones in the rat spinal cord revealed by in vivo patch recording, J. Physiol., 555, 515, 10.1113/jphysiol.2003.054932

Sudo, 2017, Antinociception induced by a novel α2A adrenergic receptor agonist in rodents acute and chronic pain models, Eur. J. Pharm., 815, 210, 10.1016/j.ejphar.2017.09.018

Schuster, 2015, Analgesic synergy between opioid and α2-adrenoceptors, Br. J. Pharm., 172, 388, 10.1111/bph.12695

Fields, 2004, State-dependent opioid control of pain, Nat. Rev. Neurosci., 5, 565, 10.1038/nrn1431

Zhao, 2007, Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward, Proc. Natl. Acad. Sci. USA, 104, 14519, 10.1073/pnas.0705740104

Hardman, J.G., Limbird, L.E., and Gilman, A.G. (2001). Catecholamines, symapthomimetic drugs, and adrenergic receptor antagonists. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, McGraw-Hill. [10th ed.].

Hemmings, H.C., and Egan, T.D. (2019). Antihypertensive drugs and vasodilators. Pharmacology and Physiology for Anesthesia Foundations and Clinical Application, Saunders. [2nd ed.].

Enna, S.J., and Bylund, D.B. (2008). Phentolamine. xPharm: The Comprehensive Pharmacology Reference, Elsevier. [1st ed.].

Vardanyan, R., and Hruby, V. (2016). Drugs for treatment of erectile dysfunction. Synthesis of Best-Seller Drugs, Academic Press. [1st ed.].

Foong, 2009, 5-HT antagonists NAN-190 and SB 269970 block alpha2-adrenoceptors in the guinea pig, Neuroreport, 20, 325, 10.1097/WNR.0b013e3283232caa

Tinajero, 1993, Serotonergic inhibition of rat Leydig cell function by propranolol, Endocrinology, 133, 257, 10.1210/endo.133.1.8391422

Can, 2013, Anti-nociceptive effect of vitexin mediated by the opioid system in mice, Pharmacol. Biochem. Behav., 109, 23, 10.1016/j.pbb.2013.04.014

Assreuy, 2013, Opioid-like antinociceptive effects of oral administration of a lectin purified from the seeds of Canavalia brasiliensis, Fundam. Clin. Pharm., 27, 201, 10.1111/j.1472-8206.2011.00987.x

Hess, 2010, Assessment of mechanisms involved in antinociception caused by myrsinoic acid B, Biol. Pharm. Bull., 33, 209, 10.1248/bpb.33.209

Fajemiroye, 2012, Involvement of 5-HT1A in the anxiolytic-like effect of dichloromethane fraction of Pimenta pseudocaryophyllus, J. Ethnopharmacol., 141, 872, 10.1016/j.jep.2012.03.043

Can, 2017, Antidepressant-like effect of gallic acid in mice: Dual involvement of serotonergic and catecholaminergic systems, Life Sci., 190, 110, 10.1016/j.lfs.2017.09.023

Schreiber, 2009, The antinociceptive properties of reboxetine in acute pain, Eur. Neuropsychopharmacol., 19, 735, 10.1016/j.euroneuro.2009.06.004

Schreiber, 2000, The antinociceptive effect of trazodone in mice is mediated through both mu-opioid and serotonergic mechanisms, Behav. Brain Res., 114, 51, 10.1016/S0166-4328(00)00185-6

Schreiber, 1999, The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms, Neurosci. Lett., 273, 85, 10.1016/S0304-3940(99)00627-8

Boschi, 1983, Antinociceptive properties of thyrotropin releasing hormone in mice: Comparison with morphine, Br. J. Pharm., 79, 85, 10.1111/j.1476-5381.1983.tb10499.x

2005, Pharmacological investigation of trimetazidine in models of inflammation, pain and gastric injury in rodents, Pharmacology, 75, 122, 10.1159/000088211

Florentino, 2018, Monoamine involvement in the antidepressant-like effect of β-caryophyllene, CNS Neurol. Disord. Drug Targets, 17, 309, 10.2174/1871527317666180420150249

Chen, 2019, GABA and 5-HT systems are involved in the anxiolytic effect of Gan-Mai-Da-Zao decoction, Front. Neurosci., 12, 1043, 10.3389/fnins.2018.01043

Santos, 2005, Mechanisms involved in the antinociception caused by agmatine in mice, Neuropharmacology, 248, 1021, 10.1016/j.neuropharm.2005.01.012

Ghelardini, 1997, Caffeine induces central cholinergic analgesia, Naunyn Schmiedebergs Arch. Pharm., 356, 590, 10.1007/PL00005094

Dunham, 1957, A note on a simple apparatus for detecting neurological deficit in rats and mice, J. Am. Pharm. Assoc., 46, 208, 10.1002/jps.3030460322

Woolfe, 1944, The evaluation of analgesic action of pethidine hydrochloride (Demerol), J. Pharm. Exp. Ther., 80, 300

Argoff, 2011, Mechanisms of pain transmission and pharmacologic management, Curr. Med. Res. Opin., 27, 2019, 10.1185/03007995.2011.614934

Gilron, 2005, Morphine, gabapentin, or their combination for neuropathic pain, N. Engl. J. Med., 352, 1324, 10.1056/NEJMoa042580

David, 2016, Pharmacological properties of vortioxetine and its pre-clinical consequences, Encephale, 42, 1S12, 10.1016/S0013-7006(16)30015-X